NEW YORK (GenomeWeb News) – The Estrogen Gene Test Co. announced on Tuesday a partnership with the Clinical Testing Laboratory to process EGT's saliva-based test for identifying polymorphisms in all of the key estrogen metabolism genes.
Clinical Testing Lab, a division of General Genetics, is CLIA-certified and provides genetic analysis services, including pharmacogenomics, genotyping, and other sequencing services.
Financial and other terms of the deal were not disclosed.
EGT's test called EstroGene was launched this week and investigates the key genes involved in estrogen metabolism.
EGT is an outgrowth of the work of the Hormonal Cancer Foundation and promotes estrogen metabolism genetic testing. General Genetics provides genetic testing services for the relationship, forensics, and clinical markets.